Status:
COMPLETED
Colon Preparation With 2L PEG in Combination With Lubiprostone vs 4L PEG
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Indication for Modification of Patient Status (Diagnosis)
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Colonoscopy is the current standard method for examination of the colon. Bowel cleansing prior to colonoscopy is the essential prerequisite to ensure complete mucosal visualization and lesion identifi...
Detailed Description
Study design: This was a single center prospective, single-blind, randomized controlled trial to compare the quality of bowel preparation using 2-L PEG with LB vs. 4-L PEG conducted from September 20...
Eligibility Criteria
Inclusion
- All patients between the age of 18 and 75 years with an appropriate indication for elective colonoscopy were considered eligible.
Exclusion
- We excluded patients who (i) suspected gastroparesis, gastric outlet or bowel obstruction; (ii) had a previous history of any gastrointestinal surgery apart from an appendectomy and cholecystectomy; (iii) had severe cardiac or pulmonary disease (American Society of Anesthesiologists physical status class 3 or 4), severe renal failure (creatinine clearance \<30 mL/min), decompensated liver cirrhosis or severe systemic illness; (iv) had a compromised swallowing reflex or impaired mental status; (v) were in a state of pregnancy or lactating; (vi) were hypersensitive or allergic to PEG or LB; or (vii) had a history of previous failure of adequate bowel preparation for colonoscopy.
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04138004
Start Date
December 1 2019
End Date
July 30 2021
Last Update
August 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajavithi hospital
Bangkok, Thailand, 10400